Baxter International Inc.

BAX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008 FY2007
Operating Activities
Net Income $2.21B $2.01B $1.71B
Depreciation & Amortization $638.0M $631.0M $581.0M
Depreciation $557.0M — —
Amortization $63.0M $53.0M —
Stock-Based Compensation $140.0M $146.0M $136.0M
Net Cash from Operating Activities $2.91B $2.52B $2.31B
Investing Activities
Capital Expenditures $1.01B $954.0M $692.0M
Business Acquisitions $156.0M — —
Net Cash from Investing Activities $-1.15B $-993.0M $-305.0M
Financing Activities
Dividends Paid $632.0M $546.0M $704.0M
Stock Repurchases $1.22B $1.99B $1.86B
Net Cash from Financing Activities $-1.01B $-1.93B $-1.97B
Net Change in Cash $655.0M $-408.0M $54.0M
Free Cash Flow $1.90B $1.56B $1.61B
← Newer Page 3 of 3 Older →